about
Effect of the nonpeptide thrombopoietin receptor agonist Eltrombopag on bone marrow cells from patients with acute myeloid leukemia and myelodysplastic syndromeEltrombopag inhibits the proliferation of leukemia cells via reduction of intracellular iron and induction of differentiationEltrombopag can overcome the anti-megakaryopoietic effects of lenalidomide without increasing proliferation of the malignant myelodysplastic syndrome/acute myelogenous leukemia clone.Thrombocytopenia in MDS: epidemiology, mechanisms, clinical consequences and novel therapeutic strategies.A large gene network in immature erythroid cells is controlled by the myeloid and B cell transcriptional regulator PU.1.IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cellsHSC commitment-associated epigenetic signature is prognostic in acute myeloid leukemia.Stem cell origin of myelodysplastic syndromes.A myeloid tumor suppressor role for NOL3Pharmacological inhibition of the transcription factor PU.1 in leukemia.Stem cell fate regulation by dynein motor protein Lis1.
P50
Q33385999-C026C9CF-EA0B-403C-A79B-A22879353486Q33401421-2B4FAD96-035F-4E28-B532-355B1B3DA37AQ33414087-5D6FFABE-5E21-47F6-BD15-535184E255ADQ33427023-A488C73A-E8EC-414B-9C29-5491784B08ABQ33939662-89259208-C315-4B7B-9EBF-0CDBBDA26E24Q35607293-3BF31485-9D87-4831-BDEF-FF2616832E56Q37602230-B332A3A4-A27B-4107-A4BE-31E861DF6C1FQ38171230-3E6D078A-AAD3-4680-ACE6-4262EB015CEAQ38715127-8E265974-185B-43D0-8FEC-D076EF0C4EB1Q46873766-37DCBE48-89C6-4AB2-A28E-4D2CAAD21389Q53064906-E80A4A8A-15D1-430F-8E35-3D05B575E77E
P50
description
researcher ORCID ID = 0000-0002-9534-6690
@en
wetenschapper
@nl
name
Britta Will
@ast
Britta Will
@en
Britta Will
@es
Britta Will
@nl
type
label
Britta Will
@ast
Britta Will
@en
Britta Will
@es
Britta Will
@nl
prefLabel
Britta Will
@ast
Britta Will
@en
Britta Will
@es
Britta Will
@nl
P31
P496
0000-0002-9534-6690